- Home
- APM vs CPHI Comparison
APM vs CPHI Comparison
Compare APM & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- CPHI
- Stock Information
- Founded
- APM 2010
- CPHI N/A
- Country
- APM United Kingdom
- CPHI China
- Employees
- APM N/A
- CPHI N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- APM Health Care
- CPHI Health Care
- Exchange
- APM Nasdaq
- CPHI Nasdaq
- Market Cap
- APM 5.6M
- CPHI 4.5M
- IPO Year
- APM 2018
- CPHI N/A
- Fundamental
- Price
- APM $0.99
- CPHI $1.65
- Analyst Decision
- APM
- CPHI
- Analyst Count
- APM 0
- CPHI 0
- Target Price
- APM N/A
- CPHI N/A
- AVG Volume (30 Days)
- APM 138.3K
- CPHI 119.7K
- Earning Date
- APM 05-06-2025
- CPHI 05-14-2025
- Dividend Yield
- APM N/A
- CPHI N/A
- EPS Growth
- APM N/A
- CPHI N/A
- EPS
- APM 0.00
- CPHI N/A
- Revenue
- APM N/A
- CPHI $4,528,929.00
- Revenue This Year
- APM $157,729.10
- CPHI N/A
- Revenue Next Year
- APM N/A
- CPHI N/A
- P/E Ratio
- APM $270.99
- CPHI N/A
- Revenue Growth
- APM N/A
- CPHI N/A
- 52 Week Low
- APM $0.46
- CPHI $1.20
- 52 Week High
- APM $7.49
- CPHI $4.10
- Technical
- Relative Strength Index (RSI)
- APM 51.54
- CPHI 42.78
- Support Level
- APM $0.79
- CPHI $1.34
- Resistance Level
- APM $0.97
- CPHI $1.71
- Average True Range (ATR)
- APM 0.12
- CPHI 0.28
- MACD
- APM 0.02
- CPHI 0.00
- Stochastic Oscillator
- APM 33.74
- CPHI 37.38
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.